For decades, women’s health has struggled with gaps in research and a lack of tools designed specifically for female biology. Hormone testing, in particular, has often left women with raw numbers and little clarity about what those results mean for their long-term health. A new company, Timeless Biotech, is working to change that.
Founder and CEO, Kiran Kumar says, “We’re entering a world where raw test results are never going to be enough. Deeper interpretation is a need and machine learning is how we’re going to address it. Timeless Biotech is leading the charge in AI-driven SaaS Healthcare. Same test, meaningful results, measurable improvements.”
Founded in California, the B2B SaaS startup has developed a patent pending technology that translates hormone data into actionable insights about ovarian health. Its flagship product, Menotimeuses machine learning to analyze hormone patterns from the results of a standard hormone, blood test. Instead of presenting a list of lab values, the platform calculates an individual’s “ovarian age” and provides a projection for menopause onset.
By reframing ovarian health as a central driver of longevity rather than just a reproductive milestone, Timeless Biotech aims to bring AI-driven insights to healthcare in a scalable way.
From Numbers to Answers
Hormone panels are incredibly challenging to interpret, and the feedback women receive varies depending on the provider. The company’s system seeks to reduce some of the subjectivity in how results are interpreted, running 100K conditional pathways and 1B mathematical operations to train. By training its machine learning models on hormone data and population-level insights, Menotime produces an ovarian age that places results in context and highlights what may lie ahead.
Founder and CEO Kiran Kumara biotechnology bioengineer from UC San Diego, created the company after years in the longevity industry. Frustrated with what she describes as a “freeform” approach to women’s longevity, she set out to design a tool that could provide measurable, data-driven clarity.
Timeless Biotech’s goal is to take what feels subjective and turn it into something women can actually use to advocate for their health.
Ovarian Health as a Longevity Marker
The company not only focuses on fertility issues, but it has also extended its understanding to ovarian health. Newer studies have shown that most of the changes caused by hormones affect the aging process in more than just fertility, impacting every single organ system of the body. Incorporating the tracking of ovarian health as part of longevity measures, Timeless Biotech encourages women to view menopause not as the end but as a bellwether for the overall health span.
This perspective reframes early tracking of ovarian health early as a form of proactive care. Rather than reacting to symptoms once they appear, women can have data-informed conversations with their providers earlier in life. The company describes this as a “stitch in time,” where small, timely interventions may help reduce the impact of age-related changes.
Importantly, the platform is not designed to replace medical care. Instead, it provides a foundation for better dialogue between patients and clinicians, offering a clearer picture of what hormone data means in real-world terms, defining a new category of care: ovarian longevity
The Team Behind the Technology
Timeless Biotech’s mission is shaped not only by technology but also by the lived experience of its team.
- Kiran KumarFounder & CEO, brings a blend of technical expertise and personal motivation to the project.
- Marie Humbert-Droz, PhDFounding Machine Learning Engineer, combines a PhD in Computational Chemistry from the University of Geneva with bioinformatics research experience at Stanford and ML Healthcare expert.
- Teresa FletcherCommercial Lead brings more than 20 years of experience scaling multi-million-dollar companies in healthcare startups across oncology, digital health, and clinical decision support.
This mix of backgrounds allows the company to approach women’s health from multiple angles: scientific, technological, and experiential.
Advisors with Global Expertise
Timeless Biotech is supported by a network of advisors who bring credibility across women’s health, reproductive endocrinology, and longevity research such as Dr. Amy Killen, Dr. Natalie Crawford, Kayla Barnes, Allie Egan, Alessandra Henderson and Alisa Vitti.
By combining clinical expertise with ML-driven personalized insights, the advisory board strengthens the foundation of the company’s work.
How MenoTime Works
Timeless Biotech has already established early partnerships with some leading clinics and emerging digital health companies in the space, including longevity clinics, aesthetic practices, OBGYNs, oncologists, fertility clinics, and aesthetics centers. The MenoTime system is designed to be easily integrated into existing health systems to enable easy testing and re-testing:
- Order and Test: Clinicians conduct a standard hormone panel
- Lab and Analysis: Input your patients’ blood test values and 7-10 self-report markers (eg, race, waist/hip circumference, UTI in the past 12 months, pleasure during sex)
- Results: Within minutes, receive your patient’s unique drivers of ovarian aging and access their personalized, validated protocols.
- Tracking: Retesting allows women to measure progress and see how lifestyle changes may affect ovarian health over time.
The company emphasizes that the results are designed as conversation starters with clinicians, giving women the ability to track and hack ovarian age, to potentially delay menopause onset.
Building Scalable Healthcare Through Vertical SaaS
Timeless Biotech is focused on scaling up its platform through such healthcare partnerships since it offers just a light low-cost application layer that can integrate smoothly with existing infrastructure. Through its vertical SaaS model, the company is positioned to scale more efficiently, leveraging existing infrastructure while avoiding some of the higher overhead costs associated with biotech or diagnostics. Timeless Biotech applies machine learning to standard hormone panels, offering an added layer of interpretation that may provide more context around ovarian health.
For success, the company needs people to adopt its ovarian age and menopause projections plus establish them as typical health metrics. Timeless is carving a category at the intersection of women’s health, longevity science, together with scalable SaaS through the introduction of these measures. By focusing on women’s wellness innovation, the company positions itself to drive cultural change while building sustainable growth.
Why It Matters
Timeless Biotech is positioning itself within this movement by offering a low-lift B2B SaaS application layer at the intersection of longevity science, data analytics, and women’s health. The platform makes complex longevity research more accessible and usable for organizations that want to act on it.
By giving healthcare providers and research partners actionable insights, Timeless enables faster decision-making and more personalized approaches to care. This positions the company not just as a data provider, but as an essential bridge between cutting-edge science and real-world outcomes.
For more information, visit Timeless Biotech.
This article is for informational purposes only and does not substitute for professional medical advice. If you are seeking medical advice, diagnosis or treatment, please consult a medical professional or healthcare provider.
